Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 4/20 | 0.43 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.43 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | GGH | Q92820 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | GNPAT | O15228 | 1/20 | 0.37 |
| ▸ | GGT1 | P19440 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2129341 | 1.00 | FOLH1 (0.43) | FOLH1RIMKLANAALAD2CA2CA4 | |
| SCHEMBL1311432 | 1.00 | FOLH1 (0.43) | FOLH1RIMKLANAALAD2CA2CA4 | |
| SCHEMBL4652687 | 0.98 | FOLH1 (0.42) | FOLH1RIMKLANAALAD2CA2CA4 | |
| SCHEMBL4652929 | 0.98 | FOLH1 (0.42) | FOLH1RIMKLANAALAD2CA2CA4 | |
| SCHEMBL16264925 | 0.92 | FOLH1 (0.38) | FOLH1RIMKLANAALAD2CA2CA4 | |
| SCHEMBL414800 | 0.88 | CA2 (0.45) | FOLH1RIMKLANAALAD2CA2CA4 | |
| SCHEMBL4992798 | 0.88 | CA2 (0.45) | FOLH1RIMKLANAALAD2CA2CA4 | |
| SCHEMBL15637714 | 0.88 | CA2 (0.45) | FOLH1RIMKLANAALAD2CA2CA4 | |
| SCHEMBL5825896 | 0.88 | CA2 (0.45) | FOLH1RIMKLANAALAD2CA2CA4 | |
| SCHEMBL39257 | 0.88 | CA2 (0.45) | FOLH1RIMKLANAALAD2CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7319165-B2 | Aminopolycarboxylic acid aqueous solution composition and stabilization method of aminopolycarboxlic acid | NIPPON SHOKUBAI CO., LTD. (JP) | 2008-01-15 | — | — | US | disclosed |
| US-20040171877-A1 | Aminopolycarboxylic acid aqueous solution composition and stabilization method of aminopolycarboxlic acid | NIPPON SHOKUBAI CO., LTD. (JP) | 2004-09-02 | — | — | US | disclosed |
| EP-1371630-A2 | Aminopolycarboxylic acid aqueous solution composition and stabilization method of aminopolycarboxylic acid | Nippon Shokubai Co., Ltd. (JP) | 2003-12-17 | — | — | EP | disclosed |
| EP-1287101-A1 | DETERGENT COMPOSITIONS | UNILEVER PLC (GB) | 2003-03-05 | — | — | EP | disclosed |
| WO-2001092449-A1 | DETERGENT COMPOSITIONS | UNILEVER PLC (GB) | 2001-12-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171877-A1 | Aminopolycarboxylic acid aqueous solution composition and stabilization method of aminopolycarboxlic acid | CA1, AASDHPPT, CA7 | FOLH1 89/4885RIMKLA 80/4885NAALAD2 166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.